StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

YARWBullishAnalyst Target Updateanalyst
Medium materiality5/10

Jefferies Starts Yarrow Bioscience (YARW) at Buy

Nov 16, 2026, 4:04 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish initiation with unusually large target-implied upside, tempered by the uncertainty inherent in a single analyst target.

AI summary

What happened, with direct paths to the underlying reporting

Jefferies initiated coverage of YARW with a Buy rating and a $40 target versus a posted price of $18.03, implying about 122% potential upside. This is an analyst opinion and the large implied upside warrants caution.

  • Jefferies initiated at Buy; $40 target vs. $18.03 posted price (~122% implied upside).

Key facts

  1. 01

    Target: $40

  2. 02

    Posted price: $18.03

  3. 03

    Analyst firm: Jefferies

  4. 04

    Analyst: Faisal Khurshid

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.